Skip to main content
Book cover

Endotoxin pp 549–556Cite as

The Mediation of Endotoxin-Induced Beneficial Effects by Cytokines

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 256))

Abstract

Endotoxins, when entering the circulation in sufficient amounts, elicit multiple effects that can lead to shock and death. Besides these detrimental effects, endotoxins in minute concentrations may nonspecifically contribute to regulate the steady state of host defense. Moreover, various experimental approaches have shown, already in the early years of endotoxin research, that injection of small amounts of extracted endotoxins can induce beneficial effects, such as tolerance to the pyrogenic and lethal effects of endotoxin, nonspecific resistance to microbial infections and irradiation disease, stimulation of hematopoiesis, as well as tumor regression. These beneficial effects of endotoxins have been reviewed recently (13).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Belosevic, M., Davis, C. E., Meltzer, M. S., and Nacy, C. A., 1988, Regulation of activated macrophage antimicrobial activities, Identification of lymphokines that cooperate with IFN- Y for induction of resistance to infection. J. Immunol. 141: 890.

    Google Scholar 

  2. Broxmeyer, H. E., Williams, D. E., Lu, L., Cooper, S., Anderson, S. L., Beyer, G. S., Hoffman, R., and Rubin, B. Y., 1986, The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-Y, J. Immunol. 136: 4487.

    Google Scholar 

  3. Czuprynski, C. J., and Brown, J. F., 1987, Recombinant murine interleukin-1 enhancement of nonspecific antibacterial resistance. Infect. Immun. 55: 2061.

    Google Scholar 

  4. Dinarello, C. A., 1987, The biology of interleukin 1 and comparison to tumor necrosis factor. Immunol. Letters 16: 227.

    Google Scholar 

  5. Dinarello, C. A., Cannon, J. G., and Wolff, S. M., 1988, New concepts on the pathogenesis of fever, in: “Perspectives on Bacterial Pathogenesis and Host Defense,” B. Urbaschek, ed., The University of Chicago Press, Chicago.

    Google Scholar 

  6. Ditter, B., Becker, K.-P., Urbaschek, R., and Urbaschek, B., 1983, Quantitativer Endotoxinnachweis. Automatisierter, kinetischer Limulus-Amobozyten-Lysat Mikrotiter-Test mit Messung probenabhingiger Interferenzen. ArzneimittelForsch/Drug Res. 33: 681.

    CAS  Google Scholar 

  7. Fraker, D. L., Stovroff, M. C., Merino, M. J., and Norton, J. A., 1988, Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J. Exp. Med. 168: 95.

    Google Scholar 

  8. Friedman, H., Blanchard, D. K., Newton, C., Klein, T., Stewart, II, W., Keler, T., and Nowotny, A., 1987, Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures. J. Biol. Resp. Modif. 6: 664.

    CAS  Google Scholar 

  9. Greer, G. G., and Rietschel, E. Th., 1978. Inverse relationship between the susceptibility of lipoplysaccharide (lipid A)-pretreated mice to the hypothermic and lethal effect of lipopolysaccharide. Infect. Immun. 20: 366.

    Google Scholar 

  10. Greisman, S. E., 1983, Induction of endotoxin tolerance, in: “Beneficial Effects of Endotoxins,” A. Nowotny, ed., Plenum Press, New York.

    Google Scholar 

  11. McCuskey, R. S., Urbaschek, R., McCuskey, P. A., and Urbaschek, B., 1983, In vivo microscopic observations of the responses of Kupffer cells and the hepatic microcirculation to Mycobacterium bovis BCG alone and in combination with endotoxin. Infect. Immun. 42: 362.

    Google Scholar 

  12. Neta, R., Douches, S. D., and Oppenheim, J. J., 1986, Interleukin-1 is a radioprotector. J. Immunol. 136: 2483.

    Google Scholar 

  13. Nowotny, A., 1983, “Beneficial Effects of Endotoxins,” Plenum Press New York

    Google Scholar 

  14. Ozaki, Y., Ohashi, T., Minami, A., and Nakamura, S.-I., 1987, Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-la, Infect. Immun. 55: 1436.

    Google Scholar 

  15. Rietschel, E. Th., Schade, U., Jensen, M., Wollenweber, H. W., Lüüderitz, O., and Greisman, S. E., 1982, Bacterial endotoxins: Chemical structure, biological activity and role in septicaemia. Scand. J. Infect. Dis. 31 (Suppl.): 8.

    Google Scholar 

  16. Rothstein, J. L., and Schreiber, H., 1988, Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. (USA) 85: 607.

    Google Scholar 

  17. Urbaschek, B., Ditter, B., Becker, K.-P., and Urbaschek, R., 1984, Protective effects and role of endotoxin in experimental septicemia. Circ. Shock 14: 209.

    Google Scholar 

  18. Urbaschek, R., and Urbaschek, B., 1982, Aspects of beneficial endotoxinmediated effects. Kiin. Wochenschr. 60: 746.

    Google Scholar 

  19. Urbaschek, R., and Urbaschek, B., 1983, Ability of post-endotoxin serum from BCG-infected mice to induce nonspecific resistance and stimulation of granulopoiesis. Infect. Immun. 39: 1488.

    Google Scholar 

  20. Urbaschek, R., Männel, D. N., Mergenhagen, S. E., and Urbaschek, B., 1986, The role of post-endotoxin serum components from BCG infected mice in the protection of compromised hosts, in: “Immunobiology and Immunopharmacology of Bacterial Endotoxins,” A—Szentivanyi, H. Friedman, and A. Nowotny,Plenum Press, New York.

    Google Scholar 

  21. Urbaschek, R., Iannel, D. N., and Urbaschek, B., 1987, Tumor necrosis factor induced stimulation of granulopoiesis and radioprotection. Lymph. Res. 6: 179.

    Google Scholar 

  22. Urbaschek, R., and Urbaschek, B., 1987, Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects. Rev. Infect. Dis. 9: S607.

    Google Scholar 

  23. Urbaschek, R., Urbaschek, B., and Ribi, E., 1985, Induction of nonspecific resistance, endotoxin tolerance and colony-stimulating activity (CSA) by nontoxic LPS components. Fed. Proc. 44: 1490.

    Google Scholar 

  24. Vogel, S. N., Douches, S. D., Kaufman, E. N., Neta, R., 1987, Induction of colony stimulating factor in vivo by recombinant interleukin 1 a and recombinant tumor necrosis factor a. J. Immunol. 138: 2143.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media New York

About this chapter

Cite this chapter

Urbaschek, R., Urbaschek, B. (1990). The Mediation of Endotoxin-Induced Beneficial Effects by Cytokines. In: Friedman, H., Klein, T.W., Nakano, M., Nowotny, A. (eds) Endotoxin. Advances in Experimental Medicine and Biology, vol 256. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5140-6_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5140-6_48

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-5142-0

  • Online ISBN: 978-1-4757-5140-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics